S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

• B Inusa,
• M Hamdy,
• A El-Beshlawy,
• F Ebeid,
• J Kwiatkowski,
• J Kanter,
• S Williams,
• D Lee,
• N Temin,
• C Fradette,
• F Tricta,
• M Elalfy

Affiliations

B Inusa

1 Evelina Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, UNITED KINGDOM

M Hamdy

2 Cairo University, Cairo, EGYPT

A El-Beshlawy

3 Pediatric Hospital of Cairo University, Cairo, EGYPT

F Ebeid

4 Ain Shams University, Pediatric Hospital, Cairo, EGYPT

J Kwiatkowski

5 The Children’s Hospital of Philadelphia, Philadelphia, UNITED STATES

J Kanter

6 Medical University of South Carolina, Charleston, UNITED STATES

S Williams

7 The Hospital for Sick Children, University of Toronto, Toronto, CANADA

D Lee

8 Chiesi Canada Corporation, Toronto, CANADA

N Temin

8 Chiesi Canada Corporation, Toronto, CANADA

C Fradette

8 Chiesi Canada Corporation, Toronto, CANADA

F Tricta

8 Chiesi Canada Corporation, Toronto, CANADA

M Elalfy

4 Ain Shams University, Pediatric Hospital, Cairo, EGYPT